HomeQuestion

How do you discuss the overlap of POTS, Ehlers-Danlos and MCAS with patients?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?

How often are you performing CT screening in CVID patients to screen for ILD?

Do you use Xoliar as add-on treatment for hereditary alpha tryptasemia?

Should a patient who has hereditary alpha tryptasemia and has experienced multiple anaphylactoid reactions be tested for a venom allergy and started on VIT if positive?

In which patients with CHE will you prioritize early use of delgocitinib?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

How do you discuss the overlap of POTS, Ehlers-Danlos and MCAS with patients? | Mednet